Studying Corneal Epithelial Stability Following Limbal Stem Cell Transplantation in Cases of Limbal Stem Cell Deficiency

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05494671
Collaborator
(none)
12
1
1
10
1.2

Study Details

Study Description

Brief Summary

Integrity of the corneal epithelium is the function of intact limbal stem cells. The reduction in the population of LSCs and their dysfunction result in abnormal corneal epithelialization and invasion of the corneal surface by the conjunctival epithelium with or without corneal neovascularization that is, limbal stem cell deficiency (LSCD). Different techniques have been developed to treat cases of limbal stem cell deficiency due to traumatic or congenital cases. Recent innovations developed to predict the early stages of stem cell deficiency. One of these methods is measurement of the central epithelial thickness as it was found that limbal stem cell deficiency causes reduction of the central epithelial thickness.

The aim of this study is to study changes in the corneal epithelial thickness at different quadrants of the cornea to observe the exact time of epithelial stability following stem cell transplantation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: conjunctival limbal autologous transplant
N/A

Detailed Description

Patients with unilateral chemical ocular injury will be included in the study(12 eyes). All selected patients will receive a thorough explanation of the study design and aims and informed consent will be obtained in all patients. Eyes of all participants will be subjected to: Best corrected visual acuity, Slit lamp examination and ocular ultrasound if no fundus view.

Staging of degree of limbal stem cell deficiency is done by Roper Hall classification and then the patient will have conjunctival limbal autologous transplant (CLAU).

The patient will be followed up at a week, a month, 3 months, 6months and 9 months postoperative.

Corneal epithelial mapping will be done at the previous schedule in both the donated and the recipient eyes using anterior segment OCT (Optical Coherence Tomography)

Exclusion criteria:

Bilateral cases and patients with severe conjunctival scaring and symblepharon.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
interventional case seriesinterventional case series
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Studying Corneal Epithelial Stability Following Limbal Stem Cell Transplantation in Cases of Limbal Stem Cell Deficiency
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: conjunctival limbal autologous transplant

patients with unilateral stem cell deficiency due to chemical burn

Procedure: conjunctival limbal autologous transplant
Patients with unilateral chemical ocular injury will be included in the study. All selected patients will receive a thorough explanation of the study design and aims and informed consent will be obtained in all patients. Eyes of all participants will be subjected to: Best corrected visual acuity, Slit lamp examination and ocular ultrasound if no fundus view. Staging of degree of limbal stem cell deficiency is done by Roper Hall classification and then the patient will have conjunctival limbal autologous transplant (CLAU)

Outcome Measures

Primary Outcome Measures

  1. the change of corneal epithelial thickness after stem cell transplantation over 9 months [9 months]

    Corneal epithelial mapping will be done at one month, 3,6 and 9 months in both the donated and the recipient eyes using anterior segment OCT at the center

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients between 15 to 70 years

  • Unilateral limbal stem cell deficiency

  • Grade 4 stem cell deficiency

Exclusion Criteria:
  • Cases with extensive symblepharon

  • Cases with very poor visual acuity ( no light perception)

  • Cases with posterior segment problem evident in ocular ultrasonography

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Alainy Cairo Egypt 11562

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fayrouz Aboalazayem, principal investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT05494671
Other Study ID Numbers:
  • N-14-2022
First Posted:
Aug 10, 2022
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fayrouz Aboalazayem, principal investigator, Cairo University

Study Results

No Results Posted as of Aug 11, 2022